Bhubaneswar: The Institute of Life Science (ILS), Bhubaneswar, has been chosen as one of the 16 biorepository centres in the country for COVID-19 clinical samples.
The government of India is looking to increase research and development efforts in order to create new diagnostics, therapeutics and vaccines in the future. The repository will collect, store and maintain clinical samples (oropharyngeal/nasopharyngeal swabs, bronchoalveolar lavage, sputum, blood, urine and stool) of coronavirus patients.
The institute will be authorized to share these samples with academia, industry and commercial entities involved in development of diagnostics, therapeutics, vaccines after scrutinization. The purpose of sharing clinical specimens and the intended use will be examined by the National Oversight Committee as well as the Institutional Human Ethics Committee.
New Delhi: After the record-breaking success of ‘Pushpa 2: The Rule’, Rashmika Mandanna has her…
Bhubaneswar: Twelve members of Village Water and Sanitation Committees (VWSC) from nine districts of Odisha…
Hyderabad: Bollywood actress Janhvi Kapoor, who is rumoured to be dating Shikhar Pahariya, had once…
Bhubaneswar: In a remarkable stride toward strengthening industrial ecosystem, the Odisha government on Wednesday approved…
Bengaluru: Playing away from home, Odisha FC turned the game on its head to snatch a…
Hyderabad: Two weeks after its Telugu release, the Hindi version of Balakrishna-Urvashi Rautela starrer ‘Daaku…
This website uses cookies.
